Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pralay Mitra

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Letters|July 5, 2022
Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastomaAngana Biswas, Yetirajam Rajesh, Subhayan Das, et al.
Plos Computational Biology|November 9, 2013
An evolution-based approach to De Novo protein design and case study on Mycobacterium tuberculosisPralay Mitra, David Shultis, Jeffrey R Brender, et al.
Journal of Ovarian Research|August 2, 2024
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancerSiddik Sarkar, Sarbar Ali Saha, Abhishek Swarnakar, et al.
Journal of Medicinal Chemistry|February 16, 2026
Targeting of HSP27 and MMP-2/9 Crosstalk by High-Throughput Drug Repurposing Strategies Identifies Paroxetine as a Potential Candidate in GlioblastomaSuvendu Nandi, Shreya Banerjee, Debolina Manna, et al.
Biochimica Et Biophysica Acta. General Subjects|April 28, 2019
Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma managementY Rajesh, Anupam Banerjee, Ipsita Pal, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.
Journal of Molecular Biology|January 10, 2019
Changing the Apoptosis Pathway through Evolutionary Protein DesignDavid Shultis, Pralay Mitra, Xiaoqiang Huang, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Letters|July 5, 2022
Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastomaAngana Biswas, Yetirajam Rajesh, Subhayan Das, et al.
Plos Computational Biology|November 9, 2013
An evolution-based approach to De Novo protein design and case study on Mycobacterium tuberculosisPralay Mitra, David Shultis, Jeffrey R Brender, et al.
Journal of Ovarian Research|August 2, 2024
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancerSiddik Sarkar, Sarbar Ali Saha, Abhishek Swarnakar, et al.
Journal of Medicinal Chemistry|February 16, 2026
Targeting of HSP27 and MMP-2/9 Crosstalk by High-Throughput Drug Repurposing Strategies Identifies Paroxetine as a Potential Candidate in GlioblastomaSuvendu Nandi, Shreya Banerjee, Debolina Manna, et al.
Biochimica Et Biophysica Acta. General Subjects|April 28, 2019
Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma managementY Rajesh, Anupam Banerjee, Ipsita Pal, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.
Journal of Molecular Biology|January 10, 2019
Changing the Apoptosis Pathway through Evolutionary Protein DesignDavid Shultis, Pralay Mitra, Xiaoqiang Huang, et al.
Pageof 4